Detection

• New Zealand-based a2 Milk Company voluntarily recalled a2 Platinum Premium USA label infant formula 0-12 months with batch numbers 2210269454, 2210324609, and 2210321712, sold on Amazon and at Meijer stores. • The recall was initiated after testing detected cereulide, a heat-stable toxin from Bacillus cereus, following New Zealand regulatory guidance, with no confirmed illnesses reported by the FDA. • A total of 16,428 tins were affected, imported during the 2022 Operation Fly Formula to address U.S. shortages; the product was discontinued prior to the recall.

• NASA's Perseverance rover discovered extensive water ice deposits beneath Mars' surface in Jezero Crater using advanced ground-penetrating radar technology, with findings suggesting accessibility for future human missions. • The subsurface ice layers extend up to 300 meters deep and contain an estimated 5 million metric tons of water ice, according to data released by NASA's Jet Propulsion Laboratory on April 21. • Scientists believe the water deposits could support long-term human habitation and fuel production, making Mars exploration more feasible for sustained presence beyond current rover missions.

• Fraud incidents continue climbing at US banks even with substantial spending on advanced detection tools and analytics. • The gap highlights limitations in current tech defenses against evolving fraudster tactics. • This trend matters as it pressures financial institutions to innovate faster, amid rising economic impacts from cyber fraud.

• Anthropic launched Project Glasswing, collaborating with Apple, Google, and Microsoft to deploy Claude Mythos Preview in identifying and patching critical software vulnerabilities preemptively. • The initiative unites rivals to leverage AI against cyber threats targeting US software infrastructure. • By fixing flaws before exploitation, the project aims to bolster national cybersecurity amid escalating AI-driven attacks.

• Researchers at Johns Hopkins University published findings in Nature Medicine on March 20 showing a blood test can detect Alzheimer's pathology 15-20 years before symptom onset with 94% accuracy. • The test measures phosphorylated tau and amyloid-beta levels and was validated in 2,100 cognitively normal participants followed for up to 12 years in multiple longitudinal cohorts. • Early detection could enable preventive interventions during the asymptomatic stage, potentially delaying or preventing cognitive decline in the 6 million Americans living with Alzheimer's disease.